Markets Gone Wild

Data Supports Deramiocel’s Sustained Efficacy and Safety in Treating DMD Improvements Seen in Multiple Cardiac and Skeletal Endpoints Demonstrating Stabilization of Cardiac and Skeletal Muscle Function Over 3 Years of Treatment Company on Track to Fully Submit Biologics License Application (BLA) by End of 2024 SAN DIEGO, Oct. 11, 2024 (GLOBE NEWSWIRE) — Capricor Therapeutics…

Rosen Law Firm Files Class Action Lawsuit Against Quantum Computing Inc. Rosen Law Firm, a renowned global investor rights law firm, has announced the filing of a class action lawsuit against Quantum Computing Inc. (QUBT) on behalf of purchasers of the company’s securities during the period between March 30, 2020, and January 15, 2025. The…

Sanofi announces buy back of shares from L’Oréal Paris February 3, 2025 Sanofi, a leading pharmaceutical company, made a significant announcement today regarding the acquisition of 2.3% of its shares from long-standing shareholder L’Oréal. This strategic move signals a shift in ownership and financial structure for both companies, with potential implications for the future. Sanofi…

Regeneron Pharmaceuticals Faces Securities Fraud Class Action Investigation into Misleading Marketing Practices San Francisco, CA / ACCESS Newswire / January 28, 2025 / Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is currently under fire as they face a securities fraud class action following a significant drop in their stock value on October 31, 2024. The plummeting of shares…